Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects by Berindan-Neagoe I, Braicu C, Irimie A

Get full text

Nanopharmacology in translational hematology and oncology by Tomuleasa C, Braicu C, Irimie A, Craciun L, Berindan-Neagoe I

Get full text

The new era of nanotechnology, an alternative to change cancer treatment by Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I

Get full text

RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy by Buduru S, Zimta AA, Ciocan C, Braicu C, Dudea D, Irimie AI, Berindan-Neagoe I

Get full text

Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer by Irimie AI, Sonea L, Jurj A, Mehterov N, Zimta AA, Budisan L, Braicu C, Berindan-Neagoe I

Get full text

Clinical and pathological implications of miRNA in bladder cancer by Braicu C, Cojocneanu-Petric R, Chira S, Truta A, Floares A, Petrut B, Achimas-Cadariu P, Berindan-Neagoe I

Get full text

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells by Obasi TC, Braicu C, Iacob BC, Bodoki E, Jurj A, Raduly L, Oniga I, Berindan-Neagoe I, Oprean R

Get full text

MicroRNA Dysregulation in Prostate Cancer by Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-Neagoe I

Get full text